Related Experiment Video
Updated: Jul 23, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Angio-based coronary functional assessment predicts 30-day new-onset heart failure after acute myocardial infarction
Da Luo1,2,3, Hui Wu4,5, Wenjie Zhou1,2,3
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Insights
Coronary flow velocity (CFV) after primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI) predicts heart failure (HF). Low CFV (<17.4 cm/s) indicates high HF risk, even with restored epicardial flow.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Physiology
Background:
- Suboptimal myocardial perfusion post-ST-segment elevation myocardial infarction (STEMI) despite successful primary percutaneous coronary intervention (PPCI) remains a significant cause of heart failure (HF).
- Current assessment methods may not fully capture the microvascular dysfunction contributing to adverse outcomes.
Purpose of the Study:
- To evaluate the clinical implications of angio-based coronary functional assessment in identifying suboptimal perfusion and predicting outcomes in STEMI patients after PPCI.
- To determine the role of quantitative flow ratio (QFR), angio-based microvascular resistance (AMR), and coronary flow velocity (CFV) in risk stratification for new-onset HF.
Main Methods:
- Retrospective analysis of 942 STEMI patients from the Chinese STEMI PPCI registry trial who achieved Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow post-PPCI.
- Calculation of post-procedural QFR, AMR, and CFV of the infarct-related artery.
- Kaplan-Meier analysis, Cox regression, and receiver-operating characteristic (ROC) curve analysis to assess the association between functional parameters and 30-day new-onset HF.
Main Results:
- Patients with combined low QFR and high AMR (QFR+/AMR+) had significantly higher HF incidence (27.3%) compared to those with optimal parameters (QFR-/AMR-, 10.5%).
- A higher CFV (≥17.4 cm/s) was associated with lower HF incidence (10.3%) compared to lower CFV (<17.4 cm/s, 16.8%).
- Post-PPCI CFV was an independent predictor of post-STEMI HF (adjusted hazard ratio: 0.61; P=0.012), with an ROC area under the curve of 0.749 for the predictive model.
Conclusions:
- Coronary flow velocity (CFV) serves as an integrated measure of coronary physiology, reflecting both epicardial and microcirculatory function.
- STEMI patients with post-PPCI CFV <17.4 cm/s face a high risk of new-onset HF, irrespective of TIMI 3 flow achievement.
- Immediate angio-based coronary functional assessment, particularly CFV, is a valuable tool for evaluating suboptimal perfusion and stratifying HF risk post-STEMI.
Aims:
Suboptimal perfusion leading to heart failure (HF) often occurs after ST-segment elevation myocardial infarction (STEMI), despite restoration of epicardial coronary flow in primary percutaneous coronary intervention (PPCI) era. We determined the clinical implications of angio-based coronary functional assessment in evaluation of suboptimal perfusion and further outcomes among STEMI patients after successful PPCI.
Methods And Results:
In this study, STEMI patients in the Chinese STEMI PPCI registry trial (NCT04996901) who achieved post-PPCI thrombolysis in myocardial infarction grade 3 flow were retrospectively screened. Post-procedural quantitative flow ratio (QFR), angio-based microvascular resistance (AMR), and coronary flow velocity (CFV) of the infarct-related artery were calculated. QFR and AMR measure epicardial stenosis severity and microvascular resistance, respectively. QFR+ was defined as QFR < 0.90 while QFR- was QFR ≥ 0.90. AMR+ was defined as AMR ≥ 250 mmHg*s/m while AMR- was AMR < 250 mmHg*s/m. The primary outcome was 30-day new-onset HF. The Kaplan-Meier curves were used to establish the associations between QFR, AMR, CFV, and HF incidences. The relationship between CFV and combined QFR and AMR indices was further assessed. Independent predictors were determined using Cox regression analysis. The receiver-operating characteristic curve was used to assess discriminant ability to predict HF. A total of 942 patients (mean age was 57.8 ± 11.7 years and 84.6% were men) were enrolled. Among them, 129 patients had new-onset HF episodes. Patients in the QFR-/AMR- group had a low risk of HF compared with those in the QFR+/AMR+ group (10.5% vs. 27.3%, P = 0.027). A higher CFV ≥ 17.4 cm/s was associated with low HF incidences as compared with CFV < 17.4 cm/s (10.3% vs. 16.8%, P = 0.005), whereas isolated QFR or AMR did not reveal any marked differences in HF incidences (P = 0.150 and 0.079, respectively). The highest and lowest medians of CFV were observed in the QFR-/AMR- and QFR+/AMR+ groups, respectively. CFV correlated well with the QFR/AMR ratio (adjusted R2 = 1, P < 0.001) and post-PPCI CFV was found to be an independent predictor of post-STEMI HF (adjusted hazard ratio: 0.61, 95% confidence interval: 0.41-0.90, P = 0.012). The area under curve estimate of the multivariable regression model was 0.749.
Conclusions:
CFV is an integrated coronary physiological assessment approach that incorporates epicardial and microcirculatory contributions. Patients with post-PPCI CFV < 17.4 cm/s were strongly associated with a high risk for post-STEMI HF, even achieving thrombolysis in myocardial infarction grade 3 flow. The immediate angio-based coronary functional assessment is a feasible tool for evaluating suboptimal perfusion and risk stratification.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Acute Coronary Syndrome V: Nursing Management

